BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 24091628)

  • 21. Regulation of GATA-binding protein 2 levels via ubiquitin-dependent degradation by Fbw7: involvement of cyclin B-cyclin-dependent kinase 1-mediated phosphorylation of THR176 in GATA-binding protein 2.
    Nakajima T; Kitagawa K; Ohhata T; Sakai S; Uchida C; Shibata K; Minegishi N; Yumimoto K; Nakayama KI; Masumoto K; Katou F; Niida H; Kitagawa M
    J Biol Chem; 2015 Apr; 290(16):10368-81. PubMed ID: 25670854
    [TBL] [Abstract][Full Text] [Related]  

  • 22. F-box and WD repeat domain-containing-7 (Fbxw7) protein targets endoplasmic reticulum-anchored osteogenic and chondrogenic transcriptional factors for degradation.
    Yumimoto K; Matsumoto M; Onoyama I; Imaizumi K; Nakayama KI
    J Biol Chem; 2013 Oct; 288(40):28488-502. PubMed ID: 23955342
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A nucleolar isoform of the Fbw7 ubiquitin ligase regulates c-Myc and cell size.
    Welcker M; Orian A; Grim JE; Eisenman RN; Clurman BE
    Curr Biol; 2004 Oct; 14(20):1852-7. PubMed ID: 15498494
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fbxw7/Cdc4 is a p53-dependent, haploinsufficient tumour suppressor gene.
    Mao JH; Perez-Losada J; Wu D; Delrosario R; Tsunematsu R; Nakayama KI; Brown K; Bryson S; Balmain A
    Nature; 2004 Dec; 432(7018):775-9. PubMed ID: 15592418
    [TBL] [Abstract][Full Text] [Related]  

  • 25. FBXW7 Facilitates Nonhomologous End-Joining via K63-Linked Polyubiquitylation of XRCC4.
    Zhang Q; Karnak D; Tan M; Lawrence TS; Morgan MA; Sun Y
    Mol Cell; 2016 Feb; 61(3):419-433. PubMed ID: 26774286
    [TBL] [Abstract][Full Text] [Related]  

  • 26. FBXW7/hCDC4 is a general tumor suppressor in human cancer.
    Akhoondi S; Sun D; von der Lehr N; Apostolidou S; Klotz K; Maljukova A; Cepeda D; Fiegl H; Dafou D; Marth C; Mueller-Holzner E; Corcoran M; Dagnell M; Nejad SZ; Nayer BN; Zali MR; Hansson J; Egyhazi S; Petersson F; Sangfelt P; Nordgren H; Grander D; Reed SI; Widschwendter M; Sangfelt O; Spruck C
    Cancer Res; 2007 Oct; 67(19):9006-12. PubMed ID: 17909001
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MDM2 and Fbw7 cooperate to induce p63 protein degradation following DNA damage and cell differentiation.
    Galli F; Rossi M; D'Alessandra Y; De Simone M; Lopardo T; Haupt Y; Alsheich-Bartok O; Anzi S; Shaulian E; Calabrò V; La Mantia G; Guerrini L
    J Cell Sci; 2010 Jul; 123(Pt 14):2423-33. PubMed ID: 20571051
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of the ubiquitin ligase Fbw7 in cancer progression.
    Cheng Y; Li G
    Cancer Metastasis Rev; 2012 Jun; 31(1-2):75-87. PubMed ID: 22124735
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MiRNA-27a controls FBW7/hCDC4-dependent cyclin E degradation and cell cycle progression.
    Lerner M; Lundgren J; Akhoondi S; Jahn A; Ng HF; Akbari Moqadam F; Oude Vrielink JA; Agami R; Den Boer ML; Grandér D; Sangfelt O
    Cell Cycle; 2011 Jul; 10(13):2172-83. PubMed ID: 21597324
    [TBL] [Abstract][Full Text] [Related]  

  • 30. FBXW7 Confers Radiation Survival by Targeting p53 for Degradation.
    Cui D; Xiong X; Shu J; Dai X; Sun Y; Zhao Y
    Cell Rep; 2020 Jan; 30(2):497-509.e4. PubMed ID: 31940492
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Negative regulation of the stability and tumor suppressor function of Fbw7 by the Pin1 prolyl isomerase.
    Min SH; Lau AW; Lee TH; Inuzuka H; Wei S; Huang P; Shaik S; Lee DY; Finn G; Balastik M; Chen CH; Luo M; Tron AE; Decaprio JA; Zhou XZ; Wei W; Lu KP
    Mol Cell; 2012 Jun; 46(6):771-83. PubMed ID: 22608923
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fbxw7 acts as an E3 ubiquitin ligase that targets c-Myb for nemo-like kinase (NLK)-induced degradation.
    Kanei-Ishii C; Nomura T; Takagi T; Watanabe N; Nakayama KI; Ishii S
    J Biol Chem; 2008 Nov; 283(45):30540-8. PubMed ID: 18765672
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Fbw7 tumor suppressor regulates nuclear factor E2-related factor 1 transcription factor turnover through proteasome-mediated proteolysis.
    Biswas M; Phan D; Watanabe M; Chan JY
    J Biol Chem; 2011 Nov; 286(45):39282-9. PubMed ID: 21953459
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fbw7α and Fbw7γ collaborate to shuttle cyclin E1 into the nucleolus for multiubiquitylation.
    Bhaskaran N; van Drogen F; Ng HF; Kumar R; Ekholm-Reed S; Peter M; Sangfelt O; Reed SI
    Mol Cell Biol; 2013 Jan; 33(1):85-97. PubMed ID: 23109421
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fbxw7 acts as a critical fail-safe against premature loss of hematopoietic stem cells and development of T-ALL.
    Matsuoka S; Oike Y; Onoyama I; Iwama A; Arai F; Takubo K; Mashimo Y; Oguro H; Nitta E; Ito K; Miyamoto K; Yoshiwara H; Hosokawa K; Nakamura Y; Gomei Y; Iwasaki H; Hayashi Y; Matsuzaki Y; Nakayama K; Ikeda Y; Hata A; Chiba S; Nakayama KI; Suda T
    Genes Dev; 2008 Apr; 22(8):986-91. PubMed ID: 18367647
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNA-223 regulates cyclin E activity by modulating expression of F-box and WD-40 domain protein 7.
    Xu Y; Sengupta T; Kukreja L; Minella AC
    J Biol Chem; 2010 Nov; 285(45):34439-46. PubMed ID: 20826802
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The two faces of FBW7 in cancer drug resistance.
    Wang Z; Fukushima H; Gao D; Inuzuka H; Wan L; Lau AW; Liu P; Wei W
    Bioessays; 2011 Nov; 33(11):851-9. PubMed ID: 22006825
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fbw7 and p53 cooperatively suppress advanced and chromosomally unstable intestinal cancer.
    Grim JE; Knoblaugh SE; Guthrie KA; Hagar A; Swanger J; Hespelt J; Delrow JJ; Small T; Grady WM; Nakayama KI; Clurman BE
    Mol Cell Biol; 2012 Jun; 32(11):2160-7. PubMed ID: 22473991
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fbw7 dimerization determines the specificity and robustness of substrate degradation.
    Welcker M; Larimore EA; Swanger J; Bengoechea-Alonso MT; Grim JE; Ericsson J; Zheng N; Clurman BE
    Genes Dev; 2013 Dec; 27(23):2531-6. PubMed ID: 24298052
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FBXW7-mutated colorectal cancer cells exhibit aberrant expression of phosphorylated-p53 at Serine-15.
    Li N; Lorenzi F; Kalakouti E; Normatova M; Babaei-Jadidi R; Tomlinson I; Nateri AS
    Oncotarget; 2015 Apr; 6(11):9240-56. PubMed ID: 25860929
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.